Tiny proteins from camels and llamas, known as nanobodies, offer new hope for brain diseases. These molecules can enter brain ...

The newly merged university opened its $100 million Center for Brain Health and is making strides in treatment of Alzheimer's ...

The roadmap to fighting Alzheimer’s disease is a matter of updating government policy to match the current science.

She might not have been able to do that for her grandmother. But she can for other families. In honor of her grandmother, ...

Company plans to request re-examination after CHMP opinion feedback following its oral explanation FDA advises Company to meet and discuss Company’s Alzheimer's Disease clinical trial results NEW YORK ...

Anavex Life Sciences ( ($AVXL) ) has issued an update. On November 14, 2025, Anavex Life Sciences announced that the Committee for Medicinal ...

Anavex Life Sciences said European regulators informed it of a negative trend vote related to its application for its blarcamesine treatment of early Alzheimer's disease. The Committee for Medicinal ...

A new study shows that lecanemab, an amyloid-clearing Alzheimer’s therapy, does not improve the brain’s waste-removal network ...

In August 2024, LEQEMBI was approved for the treatment of mild cognitive impairment (MCI) and mild dementia due to Alzheimer’s disease (AD) in adult patients that are apolipoprotein E ε4 (ApoE ε4)* ...

To help ease that burden, the Alzheimer's Foundation of America is hosting a free educational conference on Nov. 19 in Boca Raton. Participants will learn from experts in the field of Alzheimer's ...

My personal journey proves confronting Alzheimer’s can transform lives — and that public action is essential. It is a wake-up ...